z-logo
open-access-imgOpen Access
Clinical characters and treatments of retinal vasoproliferative tumors
Author(s) -
Yiming Huang,
ShihJen Chen
Publication year - 2016
Publication title -
taiwan journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.519
H-Index - 9
eISSN - 2211-5072
pISSN - 2211-5056
DOI - 10.1016/j.tjo.2016.04.003
Subject(s) - medicine , vitrectomy , epiretinal membrane , retinal , retinal detachment , ophthalmology , visual acuity , stain , pathology , surgery , staining
Retinal vasoproliferative tumors (VPT) are uncommon benign vascular tumors. They mostly occur in healthy patients, but may be associated with other chorioretinal diseases. Here we report four patients with VPT at a referral center from 2006 to 2015. Three patients denied any past history and one had a history of retinal detachment surgery. VPT-related complications included epiretinal membrane (ERM) ( n = 2), cystoids macular edema ( n = 1), and lamellar hole combined with dense cataract, rigid anterior capsule and vitreous opacity ( n = 1). Treatments for VPT and comorbidities included vitrectomy (VT) and membrane peeling with tumor resection ( n = 2), a combined treatment of photodynamic therapy (PDT) and intravitreal injection (IVI) of anti-vascular endothelial growth factor (anti-VEGF) ( n = 2). Tumor shrinkage was achieved in both patients treated with PDT and IVI of anti-VEGF injection. The other two patients with ERM were successfully treated with VT and tumor resection. Visual acuity improved at least two lines in three patients, and one patient had decreased vision due to cataract formation after VT. Pathology of the resected tumor in one case revealed massive gliosis with positive stain of vascular endothelial cells and glial fibrillary acidic protein stain. Yet the peeled membrane was acellular. Possible beneficial treatments for VPT and comorbidities include PDT combined with IVI of anti-VEGF, or VT and membrane peeling with tumor resection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here